{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:04:21Z","timestamp":1784761461603,"version":"3.55.0"},"reference-count":170,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":59,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100013105","name":"Shanghai Rising-Star Program","doi-asserted-by":"publisher","award":["24QA2704700"],"award-info":[{"award-number":["24QA2704700"]}],"id":[{"id":"10.13039\/501100013105","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371506"],"award-info":[{"award-number":["82371506"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32260207"],"award-info":[{"award-number":["32260207"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Brain Science and Brain-like Intelligence Technology-National Science and Technology Major Project","award":["2022ZD0214000"],"award-info":[{"award-number":["2022ZD0214000"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-026-04955-0","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T02:44:45Z","timestamp":1779677085000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Executive function profiles identify stable schizophrenia subtypes with distinct symptoms, biological markers and treatment responses: a cross-time clustering and validation study"],"prefix":"10.1186","volume":"24","author":[{"given":"Tongyi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoning","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9476-1737","authenticated-orcid":false,"given":"Ji","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9585-8306","authenticated-orcid":false,"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"4955_CR1","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1192\/j.eurpsy.2022.2316","volume":"65","author":"A Vita","year":"2022","unstructured":"Vita A, Gaebel W, Mucci A, Sachs G, Erfurth A, Barlati S, et al. European Psychiatric Association guidance on assessment of cognitive impairment in schizophrenia. Eur Psychiatry. 2022;65:e58. https:\/\/doi.org\/10.1192\/j.eurpsy.2022.2316.","journal-title":"Eur Psychiatry"},{"key":"4955_CR2","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1038\/s41380-023-01949-9","volume":"28","author":"RA McCutcheon","year":"2023","unstructured":"McCutcheon RA, Keefe RSE, McGuire PK. Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment. Mol Psychiatry. 2023;28:1902\u201318. https:\/\/doi.org\/10.1038\/s41380-023-01949-9.","journal-title":"Mol Psychiatry"},{"key":"4955_CR3","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1037\/0894-4105.12.3.426","volume":"12","author":"RW Heinrichs","year":"1998","unstructured":"Heinrichs RW, Zakzanis KK. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology. 1998;12:426\u201345. https:\/\/doi.org\/10.1037\/0894-4105.12.3.426.","journal-title":"Neuropsychology"},{"key":"4955_CR4","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1093\/schbul\/sbx155","volume":"44","author":"J Gold","year":"2018","unstructured":"Gold J, Robinson B, Leonard C, Hahn B, Chen S, McMahon R, et al. Selective attention, working memory, and executive function as potential independent sources of cognitive dysfunction in schizophrenia. Schizophr Bull. 2018;44:1227\u201334. https:\/\/doi.org\/10.1093\/schbul\/sbx155.","journal-title":"Schizophr Bull"},{"key":"4955_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1146\/annurev-psych-113011-143750","volume":"64","author":"A Diamond","year":"2013","unstructured":"Diamond A. Executive functions. Annu Rev Psychol. 2013;64:135\u201368. https:\/\/doi.org\/10.1146\/annurev-psych-113011-143750.","journal-title":"Annu Rev Psychol"},{"key":"4955_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.biopsych.2008.04.027","volume":"64","author":"JG Kerns","year":"2008","unstructured":"Kerns JG, Nuechterlein KH, Braver TS, Barch DM. Executive functioning component mechanisms and schizophrenia. Biol Psychiatry. 2008;64:26\u201333. https:\/\/doi.org\/10.1016\/j.biopsych.2008.04.027.","journal-title":"Biol Psychiatry"},{"key":"4955_CR7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.bandc.2012.01.008","volume":"79","author":"S Raffard","year":"2012","unstructured":"Raffard S, Bayard S. Understanding the executive functioning heterogeneity in schizophrenia. Brain Cogn. 2012;79:60\u20139. https:\/\/doi.org\/10.1016\/j.bandc.2012.01.008.","journal-title":"Brain Cogn"},{"key":"4955_CR8","doi-asserted-by":"publisher","first-page":"e0167390","DOI":"10.1371\/journal.pone.0167390","volume":"11","author":"L Anda","year":"2016","unstructured":"Anda L, Br\u00f8nnick KS, Johnsen E, Kroken RA, J\u00f8rgensen H, L\u00f8berg E-M. The course of neurocognitive changes in acute psychosis: relation to symptomatic improvement. PLoS ONE. 2016;11:e0167390. https:\/\/doi.org\/10.1371\/journal.pone.0167390.","journal-title":"PLoS ONE"},{"key":"4955_CR9","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/npp.2009.111","volume":"35","author":"DP Eisenberg","year":"2010","unstructured":"Eisenberg DP, Berman KF. Executive function, neural circuitry, and genetic mechanisms in schizophrenia. Neuropsychopharmacology. 2010;35:258\u201377. https:\/\/doi.org\/10.1038\/npp.2009.111.","journal-title":"Neuropsychopharmacology"},{"key":"4955_CR10","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ijdevneu.2010.11.003","volume":"29","author":"D Freedman","year":"2011","unstructured":"Freedman D, Brown AS. The developmental course of executive functioning in schizophrenia. Int J Dev Neurosci. 2011;29:237\u201343. https:\/\/doi.org\/10.1016\/j.ijdevneu.2010.11.003.","journal-title":"Int J Dev Neurosci"},{"key":"4955_CR11","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1017\/S0033291714001512","volume":"45","author":"A Trotta","year":"2015","unstructured":"Trotta A, Murray RM, MacCabe JH. Do premorbid and post-onset cognitive functioning differ between schizophrenia and bipolar disorder? A systematic review and meta-analysis. Psychol Med. 2015;45:381\u201394. https:\/\/doi.org\/10.1017\/S0033291714001512.","journal-title":"Psychol Med"},{"key":"4955_CR12","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/schbul\/sbt085","volume":"40","author":"E Bora","year":"2014","unstructured":"Bora E, Murray RM. Meta-analysis of cognitive deficits in ultra-high risk to psychosis and first-episode psychosis: do the cognitive deficits progress over, or after, the onset of psychosis? Schizophr Bull. 2014;40:744\u201355. https:\/\/doi.org\/10.1093\/schbul\/sbt085.","journal-title":"Schizophr Bull"},{"key":"4955_CR13","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1001\/jamapsychiatry.2013.155","volume":"70","author":"RS Kahn","year":"2013","unstructured":"Kahn RS, Keefe RSE. Schizophrenia is a cognitive illness: time for a change in focus. JAMA Psychiatry. 2013;70:1107\u201312. https:\/\/doi.org\/10.1001\/jamapsychiatry.2013.155.","journal-title":"JAMA Psychiatry"},{"key":"4955_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1176\/appi.ajp.2013.12111438","volume":"171","author":"MH Meier","year":"2014","unstructured":"Meier MH, Caspi A, Reichenberg A, Keefe RS, Fisher HL, Harrington H, et al. Neuropsychological decline in schizophrenia from the premorbid to the postonset period: evidence from a population-representative longitudinal study. Am J Psychiatry. 2014;171:91\u2013101. https:\/\/doi.org\/10.1176\/appi.ajp.2013.12111438.","journal-title":"Am J Psychiatry"},{"key":"4955_CR15","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1176\/appi.ajp.2009.09040574","volume":"167","author":"A Reichenberg","year":"2010","unstructured":"Reichenberg A, Caspi A, Harrington H, Houts R, Keefe RS, Murray RM, et al. Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study. Am J Psychiatry. 2010;167:160\u20139. https:\/\/doi.org\/10.1176\/appi.ajp.2009.09040574.","journal-title":"Am J Psychiatry"},{"key":"4955_CR16","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.neubiorev.2010.07.001","volume":"35","author":"A-KJ Fett","year":"2011","unstructured":"Fett A-KJ, Viechtbauer W, Penn DL, van Os J, Krabbendam L. The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis. Neurosci Biobehav Rev. 2011;35:573\u201388. https:\/\/doi.org\/10.1016\/j.neubiorev.2010.07.001.","journal-title":"Neurosci Biobehav Rev"},{"key":"4955_CR17","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.schres.2014.08.022","volume":"159","author":"J-Q Xu","year":"2014","unstructured":"Xu J-Q, Hui CL-M, Longenecker J, Lee EH-M, Chang W-C, Chan SK-W, et al. Executive function as predictors of persistent thought disorder in first-episode schizophrenia: a one-year follow-up study. Schizophr Res. 2014;159:465\u201370. https:\/\/doi.org\/10.1016\/j.schres.2014.08.022.","journal-title":"Schizophr Res"},{"key":"4955_CR18","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/wps.20624","volume":"18","author":"MF Green","year":"2019","unstructured":"Green MF, Horan WP, Lee J. Nonsocial and social cognition in schizophrenia: current evidence and future directions. World Psychiatry. 2019;18:146\u201361. https:\/\/doi.org\/10.1002\/wps.20624.","journal-title":"World Psychiatry"},{"key":"4955_CR19","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.neubiorev.2019.07.020","volume":"105","author":"TF Halverson","year":"2019","unstructured":"Halverson TF, Orleans-Pobee M, Merritt C, Sheeran P, Fett A-K, Penn DL. Pathways to functional outcomes in schizophrenia spectrum disorders: meta-analysis of social cognitive and neurocognitive predictors. Neurosci Biobehav Rev. 2019;105:212\u20139. https:\/\/doi.org\/10.1016\/j.neubiorev.2019.07.020.","journal-title":"Neurosci Biobehav Rev"},{"key":"4955_CR20","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.schres.2010.09.015","volume":"125","author":"RSE Keefe","year":"2011","unstructured":"Keefe RSE, Fox KH, Harvey PD, Cucchiaro J, Siu C, Loebel A. Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial. Schizophr Res. 2011;125:161\u20138. https:\/\/doi.org\/10.1016\/j.schres.2010.09.015.","journal-title":"Schizophr Res"},{"key":"4955_CR21","doi-asserted-by":"publisher","first-page":"101016","DOI":"10.1016\/j.lanwpc.2024.101016","volume":"45","author":"B Cai","year":"2024","unstructured":"Cai B, Zhu Y, Liu D, Li Y, Bueber M, Yang X, et al. Use of the Chinese version of the MATRICS Consensus Cognitive Battery to assess cognitive functioning in individuals with high risk for psychosis, first-episode schizophrenia and chronic schizophrenia: a systematic review and meta-analysis. Lancet Reg Health West Pac. 2024;45:101016. https:\/\/doi.org\/10.1016\/j.lanwpc.2024.101016.","journal-title":"Lancet Reg Health West Pac"},{"key":"4955_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.biopsych.2011.02.033","volume":"70","author":"C-M Liu","year":"2011","unstructured":"Liu C-M, Fann CS-J, Chen C-Y, Liu Y-L, Oyang Y-J, Yang W-C, et al. ANXA7, PPP3CB, DNAJC9, and ZMYND17 genes at chromosome 10q22 associated with the subgroup of schizophrenia with deficits in attention and executive function. Biol Psychiatry. 2011;70:51\u20138. https:\/\/doi.org\/10.1016\/j.biopsych.2011.02.033.","journal-title":"Biol Psychiatry"},{"key":"4955_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12916-024-03835-9","volume":"23","author":"Y Huang","year":"2025","unstructured":"Huang Y, Wang W, Hei G, Shao T, Li L, Yang Y, et al. Subgroups of cognitive impairments in schizophrenia characterized by executive function and their morphological features: a latent profile analysis study. BMC Med. 2025;23:13. https:\/\/doi.org\/10.1186\/s12916-024-03835-9.","journal-title":"BMC Med"},{"key":"4955_CR24","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s42113-021-00106-1","volume":"4","author":"D Haywood","year":"2021","unstructured":"Haywood D, Baughman FD. Multidimensionality in executive function profiles in schizophrenia: a computational approach using the Wisconsin Card Sorting Task. Comput Brain Behav. 2021;4:381\u201394. https:\/\/doi.org\/10.1007\/s42113-021-00106-1.","journal-title":"Comput Brain Behav"},{"key":"4955_CR25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1590\/1516-4446-2018-0021","volume":"41","author":"AA Berberian","year":"2019","unstructured":"Berberian AA, Gadelha A, Dias NM, Mecca TP, Comfort WE, Bressan RA, et al. Component mechanisms of executive function in schizophrenia and their contribution to functional outcomes. Braz J Psychiatry. 2019;41:22\u201330. https:\/\/doi.org\/10.1590\/1516-4446-2018-0021.","journal-title":"Braz J Psychiatry"},{"key":"4955_CR26","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1017\/S0033291721004815","volume":"53","author":"AJ Watson","year":"2023","unstructured":"Watson AJ, Giordano A, Suckling J, Barnes TR, Husain N, Jones PB, et al. Cognitive function in early-phase schizophrenia-spectrum disorder: IQ subtypes, brain volume and immune markers. Psychol Med. 2023;53:2842\u201351. https:\/\/doi.org\/10.1017\/S0033291721004815.","journal-title":"Psychol Med"},{"key":"4955_CR27","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/schbul\/sbaa157","volume":"47","author":"K Lim","year":"2021","unstructured":"Lim K, Smucny J, Barch DM, Lam M, Keefe RSE, Lee J. Cognitive subtyping in schizophrenia: a latent profile analysis. Schizophr Bull. 2021;47:712\u201321. https:\/\/doi.org\/10.1093\/schbul\/sbaa157.","journal-title":"Schizophr Bull"},{"key":"4955_CR28","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.nicl.2017.08.008","volume":"16","author":"K Ohi","year":"2017","unstructured":"Ohi K, Shimada T, Nemoto K, Kataoka Y, Yasuyama T, Kimura K, et al. Cognitive clustering in schizophrenia patients, their first-degree relatives and healthy subjects is associated with anterior cingulate cortex volume. NeuroImage Clin. 2017;16:248\u201356. https:\/\/doi.org\/10.1016\/j.nicl.2017.08.008.","journal-title":"NeuroImage Clin"},{"key":"4955_CR29","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.schres.2020.11.013","volume":"229","author":"I Fern\u00e1ndez-Linsenbarth","year":"2021","unstructured":"Fern\u00e1ndez-Linsenbarth I, Planchuelo-G\u00f3mez \u00c1, D\u00edez \u00c1, Arjona-Valladares A, de Luis R, Mart\u00edn-Santiago \u00d3, et al. Neurobiological underpinnings of cognitive subtypes in psychoses: a cross-diagnostic cluster analysis. Schizophr Res. 2021;229:102\u201311. https:\/\/doi.org\/10.1016\/j.schres.2020.11.013.","journal-title":"Schizophr Res"},{"key":"4955_CR30","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1076\/jcen.24.6.765.8402","volume":"24","author":"SK Hill","year":"2002","unstructured":"Hill SK, Ragland JD, Gur RC, Gur RE. Neuropsychological profiles delineate distinct profiles of schizophrenia, an interaction between memory and executive function, and uneven distribution of clinical subtypes. J Clin Exp Neuropsychol. 2002;24:765\u201380. https:\/\/doi.org\/10.1076\/jcen.24.6.765.8402.","journal-title":"J Clin Exp Neuropsychol"},{"key":"4955_CR31","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.jad.2020.12.090","volume":"282","author":"I Valli","year":"2021","unstructured":"Valli I, De La Serna E, Borras R, Ilzarbe D, Baeza I, Picouto MD, et al. Cognitive heterogeneity in the offspring of patients with schizophrenia or bipolar disorder: a cluster analysis across family risk. J Affect Disord. 2021;282:757\u201365. https:\/\/doi.org\/10.1016\/j.jad.2020.12.090.","journal-title":"J Affect Disord"},{"key":"4955_CR32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0924-9338(02)00648-X","volume":"17","author":"P Brazo","year":"2002","unstructured":"Brazo P, Marie RM, Halbecq I, Benali K, Segard L, Delamillieure P, et al. Cognitive patterns in subtypes of schizophrenia. Eur Psychiatry. 2002;17:155\u201362. https:\/\/doi.org\/10.1016\/S0924-9338(02)00648-X.","journal-title":"Eur Psychiatry"},{"key":"4955_CR33","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1080\/13803395.2011.578569","volume":"33","author":"SE Dawes","year":"2011","unstructured":"Dawes SE, Jeste DV, Palmer BW. Cognitive profiles in persons with chronic schizophrenia. J Clin Exp Neuropsychol. 2011;33:929\u201336. https:\/\/doi.org\/10.1080\/13803395.2011.578569.","journal-title":"J Clin Exp Neuropsychol"},{"key":"4955_CR34","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.pscychresns.2015.08.008","volume":"234","author":"D Geisler","year":"2015","unstructured":"Geisler D, Walton E, Naylor M, Roessner V, Lim KO, Charles Schulz S, et al. Brain structure and function correlates of cognitive subtypes in schizophrenia. Psychiatry Res Neuroimaging. 2015;234:74\u201383. https:\/\/doi.org\/10.1016\/j.pscychresns.2015.08.008.","journal-title":"Psychiatry Res Neuroimaging"},{"key":"4955_CR35","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1001\/jamapsychiatry.2016.2925","volume":"73","author":"D Weinberg","year":"2016","unstructured":"Weinberg D, Lenroot R, Jacomb I, Allen K, Bruggemann J, Wells R, et al. Cognitive subtypes of schizophrenia characterized by differential brain volumetric reductions and cognitive decline. JAMA Psychiatry. 2016;73:1251\u20139. https:\/\/doi.org\/10.1001\/jamapsychiatry.2016.2925.","journal-title":"JAMA Psychiatry"},{"key":"4955_CR36","doi-asserted-by":"publisher","first-page":"111136","DOI":"10.1016\/j.pscychresns.2020.111136","volume":"304","author":"LF Castro-de-Araujo","year":"2020","unstructured":"Castro-de-Araujo LF, Machado DB, Barreto ML, Kanaan RA. Subtyping schizophrenia based on symptomatology and cognition using a data driven approach. Psychiatry Res Neuroimaging. 2020;304:111136. https:\/\/doi.org\/10.1016\/j.pscychresns.2020.111136.","journal-title":"Psychiatry Res Neuroimaging"},{"key":"4955_CR37","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00406-013-0463-7","volume":"264","author":"E Gilbert","year":"2014","unstructured":"Gilbert E, M\u00e9rette C, Jomphe V, \u00c9mond C, Rouleau N, Bouchard R-H, et al. Cluster analysis of cognitive deficits may mark heterogeneity in schizophrenia in terms of outcome and response to treatment. Eur Arch Psychiatry Clin Neurosci. 2014;264:333\u201343. https:\/\/doi.org\/10.1007\/s00406-013-0463-7.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"4955_CR38","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1017\/S0033291724003507","volume":"55","author":"L Ferraro","year":"2025","unstructured":"Ferraro L, Forti MD, Barbera DL, Cascia CL, Morgan C, Tripoli G, et al. Cognitive presentation at psychosis onset through premorbid deterioration and exposure to environmental risk factors. Psychol Med. 2025;55:e12. https:\/\/doi.org\/10.1017\/S0033291724003507.","journal-title":"Psychol Med"},{"key":"4955_CR39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/13546800444000155","volume":"11","author":"G Donohoe","year":"2006","unstructured":"Donohoe G, Corvin A, Robertson I. Evidence that specific executive functions predict symptom variance among schizophrenia patients with a predominantly negative symptom profile. Cognit Neuropsychiatry. 2006;11:13\u201332. https:\/\/doi.org\/10.1080\/13546800444000155.","journal-title":"Cognit Neuropsychiatry"},{"key":"4955_CR40","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1037\/0021-843X.111.2.211","volume":"111","author":"JG Kerns","year":"2002","unstructured":"Kerns JG, Berenbaum H. Cognitive impairments associated with formal thought disorder in people with schizophrenia. J Abnorm Psychol. 2002;111:211\u201324. https:\/\/doi.org\/10.1037\/0021-843X.111.2.211.","journal-title":"J Abnorm Psychol"},{"key":"4955_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2010.05.033","volume":"121","author":"J Ventura","year":"2010","unstructured":"Ventura J, Thames AD, Wood RC, Guzik LH, Hellemann GS. Disorganization and reality distortion in schizophrenia: a meta-analysis of the relationship between positive symptoms and neurocognitive deficits. Schizophr Res. 2010;121:1\u201314. https:\/\/doi.org\/10.1016\/j.schres.2010.05.033.","journal-title":"Schizophr Res"},{"key":"4955_CR42","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.psychres.2018.12.088","volume":"272","author":"ML Thai","year":"2019","unstructured":"Thai ML, Andreassen AK, Bliksted V. A meta-analysis of executive dysfunction in patients with schizophrenia: different degree of impairment in the ecological subdomains of the Behavioural Assessment of the Dysexecutive Syndrome. Psychiatry Res. 2019;272:230\u20136. https:\/\/doi.org\/10.1016\/j.psychres.2018.12.088.","journal-title":"Psychiatry Res"},{"key":"4955_CR43","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41398-020-00962-8","volume":"10","author":"KS Ambrosen","year":"2020","unstructured":"Ambrosen KS, Skjerbaek MW, Foldager J, Axelsen MC, Bak N, Arvastson L, et al. A machine-learning framework for robust and reliable prediction of short- and long-term treatment response in initially antipsychotic-naive schizophrenia patients based on multimodal neuropsychiatric data. Transl Psychiatry. 2020;10:276. https:\/\/doi.org\/10.1038\/s41398-020-00962-8.","journal-title":"Transl Psychiatry"},{"key":"4955_CR44","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/schbul\/sbab107","volume":"48","author":"RF Soldatos","year":"2022","unstructured":"Soldatos RF, Cearns M, Nielsen M\u00d8, Kollias C, Xenaki L-A, Stefanatou P, et al. Prediction of early symptom remission in two independent samples of first-episode psychosis patients using machine learning. Schizophr Bull. 2022;48:122\u201333. https:\/\/doi.org\/10.1093\/schbul\/sbab107.","journal-title":"Schizophr Bull"},{"key":"4955_CR45","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/schbul\/sbab078","volume":"47","author":"MS Neumeier","year":"2021","unstructured":"Neumeier MS, Homan S, Vetter S, Seifritz E, Kane JM, Huhn M, et al. Examining side effect variability of antipsychotic treatment in schizophrenia spectrum disorders: a meta-analysis of variance. Schizophr Bull. 2021;47:1601\u201310. https:\/\/doi.org\/10.1093\/schbul\/sbab078.","journal-title":"Schizophr Bull"},{"key":"4955_CR46","doi-asserted-by":"publisher","first-page":"113035","DOI":"10.1016\/j.psychres.2020.113035","volume":"289","author":"M Johansson","year":"2020","unstructured":"Johansson M, Hj\u00e4rthag F, Helldin L. Cognitive markers related to long-term remission status in schizophrenia spectrum disorders. Psychiatry Res. 2020;289:113035. https:\/\/doi.org\/10.1016\/j.psychres.2020.113035.","journal-title":"Psychiatry Res"},{"key":"4955_CR47","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.schres.2012.10.011","volume":"142","author":"Y Braw","year":"2012","unstructured":"Braw Y, Benozio A, Levkovitz Y. Executive functioning during full and partial remission (positive and negative symptomatic remission) of schizophrenia. Schizophr Res. 2012;142:122\u20138. https:\/\/doi.org\/10.1016\/j.schres.2012.10.011.","journal-title":"Schizophr Res"},{"key":"4955_CR48","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.scog.2015.12.001","volume":"3","author":"T Rabanea-Souza","year":"2016","unstructured":"Rabanea-Souza T, Akiba HT, Berberian AA, Bressan RA, Dias \u00c1M, Lacerda AL. Neuropsychological correlates of remission in chronic schizophrenia subjects: the role of general and task-specific executive processes. Schizophr Res Cogn. 2016;3:39\u201346. https:\/\/doi.org\/10.1016\/j.scog.2015.12.001.","journal-title":"Schizophr Res Cogn"},{"key":"4955_CR49","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S2215-0366(23)00025-1","volume":"10","author":"S Halstead","year":"2023","unstructured":"Halstead S, Siskind D, Amft M, Wagner E, Yakimov V, Liu ZS-J, et al. Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis. Lancet Psychiatry. 2023;10:260\u201371. https:\/\/doi.org\/10.1016\/S2215-0366(23)00025-1.","journal-title":"Lancet Psychiatry"},{"key":"4955_CR50","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1007\/s12035-024-04477-x","volume":"62","author":"C-X Xu","year":"2025","unstructured":"Xu C-X, Huang W, Shi X-J, Du Y, Liang J-Q, Fang X, et al. Dysregulation of serum exosomal lipid metabolism in schizophrenia: a biomarker perspective. Mol Neurobiol. 2025;62:3556\u201367. https:\/\/doi.org\/10.1007\/s12035-024-04477-x.","journal-title":"Mol Neurobiol"},{"key":"4955_CR51","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.2147\/NDT.S411028","volume":"19","author":"X Zhu","year":"2023","unstructured":"Zhu X, Li R, Zhu Y, Zhou J, Huang J, Zhou Y, et al. Changes in inflammatory biomarkers in patients with schizophrenia: a 3-year retrospective study. Neuropsychiatr Dis Treat. 2023;19:1597\u2013604. https:\/\/doi.org\/10.2147\/NDT.S411028.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"4955_CR52","doi-asserted-by":"publisher","first-page":"114807","DOI":"10.1016\/j.bbr.2023.114807","volume":"460","author":"M-S Mojadadi","year":"2024","unstructured":"Mojadadi M-S, Mahjour M, Fahimi H, Raoofi A, Shobeiri SS. Relationship between blood-based inflammatory indices and clinical score of schizophrenia patients: a cross-sectional study. Behav Brain Res. 2024;460:114807. https:\/\/doi.org\/10.1016\/j.bbr.2023.114807.","journal-title":"Behav Brain Res"},{"key":"4955_CR53","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.psychres.2018.11.043","volume":"271","author":"S \u00d6zdin","year":"2019","unstructured":"\u00d6zdin S, B\u00f6ke \u00d6. Neutrophil\/lymphocyte, platelet\/lymphocyte and monocyte\/lymphocyte ratios in different stages of schizophrenia. Psychiatry Res. 2019;271:131\u20135. https:\/\/doi.org\/10.1016\/j.psychres.2018.11.043.","journal-title":"Psychiatry Res"},{"key":"4955_CR54","doi-asserted-by":"publisher","first-page":"e101347","DOI":"10.1136\/gpsych-2023-101347","volume":"37","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Zheng Y, Ni P, Liang S, Li X, Yu H, et al. New role of platelets in schizophrenia: predicting drug response. Gen Psychiatry. 2024;37:e101347. https:\/\/doi.org\/10.1136\/gpsych-2023-101347.","journal-title":"Gen Psychiatry"},{"key":"4955_CR55","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1038\/s41380-020-00914-0","volume":"26","author":"P Lizano","year":"2021","unstructured":"Lizano P, Lutz O, Xu Y, Rubin LH, Paskowitz L, Lee AM, et al. Multivariate relationships between peripheral inflammatory marker subtypes and cognitive and brain structural measures in psychosis. Mol Psychiatry. 2021;26:3430\u201343. https:\/\/doi.org\/10.1038\/s41380-020-00914-0.","journal-title":"Mol Psychiatry"},{"key":"4955_CR56","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.schres.2020.10.003","volume":"224","author":"T Feng","year":"2020","unstructured":"Feng T, McEvoy JP, Miller BJ. Longitudinal study of inflammatory markers and psychopathology in schizophrenia. Schizophr Res. 2020;224:58\u201366. https:\/\/doi.org\/10.1016\/j.schres.2020.10.003.","journal-title":"Schizophr Res"},{"key":"4955_CR57","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.schres.2017.06.032","volume":"193","author":"M Bioque","year":"2018","unstructured":"Bioque M, Garc\u00eda-Portilla MAP, Garc\u00eda-Rizo C, Cabrera B, Lobo A, Gonz\u00e1lez-Pinto A, et al. Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis. Schizophr Res. 2018;193:188\u201396. https:\/\/doi.org\/10.1016\/j.schres.2017.06.032.","journal-title":"Schizophr Res"},{"key":"4955_CR58","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3389\/fpsyt.2018.00622","volume":"9","author":"NE MacKenzie","year":"2018","unstructured":"MacKenzie NE, Kowalchuk C, Agarwal SM, Costa-Dookhan KA, Caravaggio F, Gerretsen P, et al. Antipsychotics, metabolic adverse effects, and cognitive function in schizophrenia. Front Psychiatry. 2018;9:622. https:\/\/doi.org\/10.3389\/fpsyt.2018.00622.","journal-title":"Front Psychiatry"},{"key":"4955_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2020.12.020","volume":"230","author":"D Enache","year":"2021","unstructured":"Enache D, Nikkheslat N, Fathalla D, Morgan BP, Lewis S, Drake R, et al. Peripheral immune markers and antipsychotic non-response in psychosis. Schizophr Res. 2021;230:1\u20138. https:\/\/doi.org\/10.1016\/j.schres.2020.12.020.","journal-title":"Schizophr Res"},{"key":"4955_CR60","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","volume":"79","author":"S Leucht","year":"2005","unstructured":"Leucht S, Kane J, Kissling W, Hamann J, Etschel E, Engel R. What does the PANSS mean? Schizophr Res. 2005;79:231\u20138. https:\/\/doi.org\/10.1016\/j.schres.2005.04.008.","journal-title":"Schizophr Res"},{"key":"4955_CR61","doi-asserted-by":"publisher","first-page":"152","DOI":"10.5395\/rde.2017.42.2.152","volume":"42","author":"H-Y Kim","year":"2017","unstructured":"Kim H-Y. Statistical notes for clinical researchers: Chi-squared test and Fisher\u2019s exact test. Restor Dent Endod. 2017;42:152\u20135. https:\/\/doi.org\/10.5395\/rde.2017.42.2.152.","journal-title":"Restor Dent Endod"},{"key":"4955_CR62","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/BF03262280","volume":"29","author":"C Tannenbaum","year":"2012","unstructured":"Tannenbaum C, Paquette A, Hilmer S, Holroyd-Leduc J, Carnahan R. A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs. Drugs Aging. 2012;29:639\u201358. https:\/\/doi.org\/10.1007\/BF03262280.","journal-title":"Drugs Aging"},{"key":"4955_CR63","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.biopsych.2019.08.031","volume":"87","author":"J Chen","year":"2020","unstructured":"Chen J, Patil KR, Weis S, Sim K, Nickl-Jockschat T, Zhou J, et al. Neurobiological divergence of the positive and negative schizophrenia subtypes identified on a new factor structure of psychopathology using non-negative factorization: an international machine learning study. Biol Psychiatry. 2020;87:282\u201393. https:\/\/doi.org\/10.1016\/j.biopsych.2019.08.031.","journal-title":"Biol Psychiatry"},{"key":"4955_CR64","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.biopsych.2020.09.024","volume":"89","author":"J Chen","year":"2021","unstructured":"Chen J, M\u00fcller VI, Dukart J, Hoffstaedter F, Baker JT, Holmes AJ, et al. Intrinsic connectivity patterns of task-defined brain networks allow individual prediction of cognitive symptom dimension of schizophrenia and are linked to molecular architecture. Biol Psychiatry. 2021;89:308\u201319. https:\/\/doi.org\/10.1016\/j.biopsych.2020.09.024.","journal-title":"Biol Psychiatry"},{"key":"4955_CR65","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jpsychires.2022.06.012","volume":"152","author":"L Duan","year":"2022","unstructured":"Duan L, Tian C, Fu C, He J, Dai J, Shao X, et al. Analysis of color vision and cognitive function in first-episode schizophrenia before and after antipsychotic treatment. J Psychiatr Res. 2022;152:278\u201388. https:\/\/doi.org\/10.1016\/j.jpsychires.2022.06.012.","journal-title":"J Psychiatr Res"},{"key":"4955_CR66","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.1192\/j.eurpsy.2023.328","volume":"66","author":"MA Tumova","year":"2023","unstructured":"Tumova MA, Stepanova AA, Yanushko MG, Kotsyubinsky AP, Ivanov MV. Antipsychotic treatment and cognitive function in patients with schizophrenia. Eur Psychiatry. 2023;66:S125\u20136. https:\/\/doi.org\/10.1192\/j.eurpsy.2023.328.","journal-title":"Eur Psychiatry"},{"key":"4955_CR67","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/pcn.12275","volume":"69","author":"T Inada","year":"2015","unstructured":"Inada T, Inagaki A. Psychotropic dose equivalence in Japan. Psychiatry Clin Neurosci. 2015;69:440\u20137. https:\/\/doi.org\/10.1111\/pcn.12275.","journal-title":"Psychiatry Clin Neurosci"},{"key":"4955_CR68","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1176\/appi.ajp.2009.09060802","volume":"167","author":"DM Gardner","year":"2010","unstructured":"Gardner DM, Murphy AL, O\u2019Donnell H, Centorrino F, Baldessarini RJ. International consensus study of antipsychotic dosing. Am J Psychiatry. 2010;167:686\u201393. https:\/\/doi.org\/10.1176\/appi.ajp.2009.09060802.","journal-title":"Am J Psychiatry"},{"key":"4955_CR69","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/S2215-0366(16)30171-7","volume":"3","author":"N Koutsouleris","year":"2016","unstructured":"Koutsouleris N, Kahn RS, Chekroud AM, Leucht S, Falkai P, Wobrock T, et al. Multisite prediction of 4-week and 52-week treatment outcomes in patients with first-episode psychosis: a machine learning approach. Lancet Psychiatry. 2016;3:935\u201346. https:\/\/doi.org\/10.1016\/S2215-0366(16)30171-7.","journal-title":"Lancet Psychiatry"},{"key":"4955_CR70","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1176\/appi.ajp.2015.14101275","volume":"172","author":"CU Correll","year":"2015","unstructured":"Correll CU, Skuban A, Ouyang J, Hobart M, Pfister S, McQuade RD, et al. Efficacy and safety of brexpiprazole for the treatment of acute schizophrenia: a 6-week randomized, double-blind, placebo-controlled trial. Am J Psychiatry. 2015;172:870\u201380. https:\/\/doi.org\/10.1176\/appi.ajp.2015.14101275.","journal-title":"Am J Psychiatry"},{"key":"4955_CR71","doi-asserted-by":"publisher","first-page":"1269322","DOI":"10.3389\/fpsyt.2023.1269322","volume":"14","author":"VHS Cordova","year":"2023","unstructured":"Cordova VHS, Teixeira AD, Anzolin AP, Moschetta R, Belmonte-de-Abreu PS. Inflammatory markers in outpatients with schizophrenia diagnosis in regular use of clozapine: a cross-sectional study. Front Psychiatry. 2023;14:1269322. https:\/\/doi.org\/10.3389\/fpsyt.2023.1269322.","journal-title":"Front Psychiatry"},{"issue":"Suppl 1","key":"4955_CR72","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.1093\/schbul\/sbl030","volume":"32","author":"M Pfammatter","year":"2006","unstructured":"Pfammatter M, Junghan UM, Brenner HD. Efficacy of psychological therapy in schizophrenia: conclusions from meta-analyses. Schizophr Bull. 2006;32(Suppl 1):S64\u201380. https:\/\/doi.org\/10.1093\/schbul\/sbl030.","journal-title":"Schizophr Bull"},{"key":"4955_CR73","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1176\/appi.ajp.2010.10060855","volume":"168","author":"T Wykes","year":"2011","unstructured":"Wykes T, Huddy V, Cellard C, McGurk SR, Czobor P. A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am J Psychiatry. 2011;168:472\u201385. https:\/\/doi.org\/10.1176\/appi.ajp.2010.10060855.","journal-title":"Am J Psychiatry"},{"key":"4955_CR74","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.4088\/JCP.10m06349","volume":"72","author":"JA Gallego","year":"2011","unstructured":"Gallego JA, Robinson DG, Sevy SM, Napolitano B, McCormack J, Lesser ML, et al. Time to treatment response in first episode schizophrenia: should acute treatment trials last several months? J Clin Psychiatry. 2011;72:1691\u20136. https:\/\/doi.org\/10.4088\/JCP.10m06349.","journal-title":"J Clin Psychiatry"},{"key":"4955_CR75","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1176\/ajp.2006.163.4.743","volume":"163","author":"R Emsley","year":"2006","unstructured":"Emsley R, Rabinowitz J, Medori R. Time course for antipsychotic treatment response in first-episode schizophrenia. Am J Psychiatry. 2006;163:743\u20135. https:\/\/doi.org\/10.1176\/ajp.2006.163.4.743.","journal-title":"Am J Psychiatry"},{"key":"4955_CR76","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1176\/appi.ajp.162.3.441","volume":"162","author":"NC Andreasen","year":"2005","unstructured":"Andreasen NC, Carpenter WT, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry. 2005;162:441\u20139. https:\/\/doi.org\/10.1176\/appi.ajp.162.3.441.","journal-title":"Am J Psychiatry"},{"key":"4955_CR77","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1126\/science.adg8538","volume":"383","author":"AM Chekroud","year":"2024","unstructured":"Chekroud AM, Hawrilenko M, Loho H, Bondar J, Gueorguieva R, Hasan A, et al. Illusory generalizability of clinical prediction models. Science. 2024;383:164\u20137. https:\/\/doi.org\/10.1126\/science.adg8538.","journal-title":"Science"},{"key":"4955_CR78","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1093\/schbul\/sby095","volume":"45","author":"MT Samara","year":"2019","unstructured":"Samara MT, Nikolakopoulou A, Salanti G, Leucht S. How many patients with schizophrenia do not respond to antipsychotic drugs in the short term? An analysis based on individual patient data from randomized controlled trials. Schizophr Bull. 2019;45:639\u201346. https:\/\/doi.org\/10.1093\/schbul\/sby095.","journal-title":"Schizophr Bull"},{"key":"4955_CR79","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261\u201376. https:\/\/doi.org\/10.1093\/schbul\/13.2.261.","journal-title":"Schizophr Bull"},{"key":"4955_CR80","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.1093\/cercor\/bhac301","volume":"33","author":"W Shi","year":"2023","unstructured":"Shi W, Fan L, Wang H, Liu B, Li W, Li J, et al. Two subtypes of schizophrenia identified by an individual-level atypical pattern of tensor-based morphometric measurement. Cereb Cortex. 2023;33:3683\u2013700. https:\/\/doi.org\/10.1093\/cercor\/bhac301.","journal-title":"Cereb Cortex"},{"key":"4955_CR81","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/s41386-026-02354-w","volume":"51","author":"Z He","year":"2026","unstructured":"He Z, He W, Chen Z, Wei W, Liu X, Dukart J, et al. Intrinsic connectivity patterns of striatal subfields predict individual dimensions of psychopathology and are associated with cholinergic and serotonergic neurotransmission in schizophrenia. Neuropsychopharmacology. 2026;51:956\u201367. https:\/\/doi.org\/10.1038\/s41386-026-02354-w.","journal-title":"Neuropsychopharmacology"},{"key":"4955_CR82","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s44220-023-00200-2","volume":"2","author":"S Zimmermann","year":"2024","unstructured":"Zimmermann S, Sakreida K, Bludau S, Camilleri JA, Hoffstaedter F, Pelzer DI, et al. Asymmetry, cytoarchitectonic morphology and genetics associated with Broca\u2019s area in schizophrenia. Nat Ment Health. 2024;2:310\u20139. https:\/\/doi.org\/10.1038\/s44220-023-00200-2.","journal-title":"Nat Ment Health"},{"key":"4955_CR83","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/j.1600-0447.1979.tb04484.x","volume":"59","author":"P Bech","year":"1979","unstructured":"Bech P, Bolwig TG, Kramp P, Rafaelsen OJ. The Bech-Rafaelsen Mania Scale and the Hamilton Depression Scale. Acta Psychiatr Scand. 1979;59:420\u201330. https:\/\/doi.org\/10.1111\/j.1600-0447.1979.tb04484.x.","journal-title":"Acta Psychiatr Scand"},{"key":"4955_CR84","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56\u201362. https:\/\/doi.org\/10.1136\/jnnp.23.1.56.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4955_CR85","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","volume":"32","author":"M Hamilton","year":"1959","unstructured":"Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50\u20135. https:\/\/doi.org\/10.1111\/j.2044-8341.1959.tb00467.x.","journal-title":"Br J Med Psychol"},{"key":"4955_CR86","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1037\/aca0000392","volume":"17","author":"X Zhao","year":"2023","unstructured":"Zhao X, Zhang W, Tong D, Maes JHR. Creative thinking and executive functions: associations and training effects in adolescents. Psychol Aesthet Creat Arts. 2023;17:79\u201390. https:\/\/doi.org\/10.1037\/aca0000392.","journal-title":"Psychol Aesthet Creat Arts"},{"key":"4955_CR87","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.cortex.2016.04.023","volume":"86","author":"NP Friedman","year":"2017","unstructured":"Friedman NP, Miyake A. Unity and diversity of executive functions: individual differences as a window on cognitive structure. Cortex. 2017;86:186\u2013204. https:\/\/doi.org\/10.1016\/j.cortex.2016.04.023.","journal-title":"Cortex"},{"key":"4955_CR88","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/0001-6918(66)90004-7","volume":"25","author":"AR Jensen","year":"1966","unstructured":"Jensen AR, Rohwer WD Jr. The Stroop color-word test: a review. Acta Psychol (Amst). 1966;25:36\u201393. https:\/\/doi.org\/10.1016\/0001-6918(66)90004-7.","journal-title":"Acta Psychol (Amst)"},{"key":"4955_CR89","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1037\/0096-3445.136.3.389","volume":"136","author":"P Gomez","year":"2007","unstructured":"Gomez P, Ratcliff R, Perea M. A model of the go\/no-go task. J Exp Psychol Gen. 2007;136:389\u2013413. https:\/\/doi.org\/10.1037\/0096-3445.136.3.389.","journal-title":"J Exp Psychol Gen"},{"key":"4955_CR90","doi-asserted-by":"publisher","first-page":"kkad016","DOI":"10.1093\/psyrad\/kkad016","volume":"3","author":"Q Zhuang","year":"2023","unstructured":"Zhuang Q, Qiao L, Xu L, Yao S, Chen S, Zheng X, et al. The right inferior frontal gyrus as pivotal node and effective regulator of the basal ganglia-thalamocortical response inhibition circuit. Psychoradiology. 2023;3:kkad016. https:\/\/doi.org\/10.1093\/psyrad\/kkad016.","journal-title":"Psychoradiology"},{"key":"4955_CR91","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1006\/brcg.2001.1505","volume":"49","author":"J Kray","year":"2002","unstructured":"Kray J, Li KZ, Lindenberger U. Age-related changes in task-switching components: the role of task uncertainty. Brain Cogn. 2002;49:363\u201381. https:\/\/doi.org\/10.1006\/brcg.2001.1505.","journal-title":"Brain Cogn"},{"key":"4955_CR92","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1037\/rev0000434","volume":"131","author":"M Yang\u00fcez","year":"2024","unstructured":"Yang\u00fcez M, Bediou B, Chanal J, Bavelier D. In search of better practice in executive functions assessment: methodological issues and potential solutions. Psychol Rev. 2024;131:402\u201330. https:\/\/doi.org\/10.1037\/rev0000434.","journal-title":"Psychol Rev"},{"key":"4955_CR93","doi-asserted-by":"publisher","first-page":"10003","DOI":"10.70322\/ldmh.2025.10003","volume":"1","author":"C Wang","year":"2025","unstructured":"Wang C, Wang J, Zeng X, Yu NX, Chen T. Are memory updating tasks valid working memory measures? A meta-analysis. Lifesp Dev Ment Health. 2025;1:10003. https:\/\/doi.org\/10.70322\/ldmh.2025.10003.","journal-title":"Lifesp Dev Ment Health"},{"key":"4955_CR94","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1037\/0033-2909.114.3.510","volume":"114","author":"R Ratcliff","year":"1993","unstructured":"Ratcliff R. Methods for dealing with reaction time outliers. Psychol Bull. 1993;114:510\u201332. https:\/\/doi.org\/10.1037\/0033-2909.114.3.510.","journal-title":"Psychol Bull"},{"key":"4955_CR95","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cortex.2023.11.012","volume":"172","author":"HD Loenneker","year":"2024","unstructured":"Loenneker HD, Buchanan EM, Martinovici A, Primbs MA, Elsherif MM, Baker BJ, et al. We don\u2019t know what you did last summer. On the importance of transparent reporting of reaction time data pre-processing. Cortex. 2024;172:14\u201337. https:\/\/doi.org\/10.1016\/j.cortex.2023.11.012.","journal-title":"Cortex"},{"key":"4955_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","volume":"45","author":"S Van Buuren","year":"2011","unstructured":"Van Buuren S, Groothuis-Oudshoorn K. mice: multivariate imputation by chained equations in R. J Stat Softw. 2011;45:1\u201367. https:\/\/doi.org\/10.18637\/jss.v045.i03.","journal-title":"J Stat Softw"},{"key":"4955_CR97","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1001\/jamapsychiatry.2024.4941","volume":"82","author":"L Dudeck","year":"2025","unstructured":"Dudeck L, Nussbaumer M, Nickl-Jockschat T, Guest PC, Dobrowolny H, Meyer-Lotz G, et al. Differences in blood leukocyte subpopulations in schizophrenia: a systematic review and meta-analysis. JAMA Psychiatry. 2025;82:492\u2013504. https:\/\/doi.org\/10.1001\/jamapsychiatry.2024.4941.","journal-title":"JAMA Psychiatry"},{"key":"4955_CR98","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1146\/annurev-clinpsy-081122-013201","volume":"20","author":"SS Gangadin","year":"2024","unstructured":"Gangadin SS, Enthoven AD, Van Beveren NJM, Laman JD, Sommer IEC. Immune dysfunction in schizophrenia spectrum disorders. Annu Rev Clin Psychol. 2024;20:229\u201357. https:\/\/doi.org\/10.1146\/annurev-clinpsy-081122-013201.","journal-title":"Annu Rev Clin Psychol"},{"key":"4955_CR99","doi-asserted-by":"publisher","first-page":"880568","DOI":"10.3389\/fpsyt.2022.880568","volume":"13","author":"EA Ermakov","year":"2022","unstructured":"Ermakov EA, Melamud MM, Buneva VN, Ivanova SA. Immune system abnormalities in schizophrenia: an integrative view and translational perspectives. Front Psychiatry. 2022;13:880568. https:\/\/doi.org\/10.3389\/fpsyt.2022.880568.","journal-title":"Front Psychiatry"},{"key":"4955_CR100","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S2215-0366(14)00122-9","volume":"2","author":"GM Khandaker","year":"2015","unstructured":"Khandaker GM, Cousins L, Deakin J, Lennox BR, Yolken R, Jones PB. Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment. Lancet Psychiatry. 2015;2:258\u201370. https:\/\/doi.org\/10.1016\/S2215-0366(14)00122-9.","journal-title":"Lancet Psychiatry"},{"key":"4955_CR101","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3389\/fnins.2015.00372","volume":"9","author":"N M\u00fcller","year":"2015","unstructured":"M\u00fcller N, Weidinger E, Leitner B, Schwarz MJ. The role of inflammation in schizophrenia. Front Neurosci. 2015;9:372. https:\/\/doi.org\/10.3389\/fnins.2015.00372.","journal-title":"Front Neurosci"},{"key":"4955_CR102","doi-asserted-by":"publisher","first-page":"e1024","DOI":"10.1038\/tp.2016.278","volume":"7","author":"OD Howes","year":"2017","unstructured":"Howes OD, McCutcheon R. Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization. Transl Psychiatry. 2017;7:e1024. https:\/\/doi.org\/10.1038\/tp.2016.278.","journal-title":"Transl Psychiatry"},{"key":"4955_CR103","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/schbul\/sbv002","volume":"41","author":"G Fond","year":"2015","unstructured":"Fond G, d\u2019Albis M-A, Jamain S, Tamouza R, Arango C, Fleischhacker WW, et al. The promise of biological markers for treatment response in first-episode psychosis: a systematic review. Schizophr Bull. 2015;41:559\u201373. https:\/\/doi.org\/10.1093\/schbul\/sbv002.","journal-title":"Schizophr Bull"},{"key":"4955_CR104","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.psyneuen.2012.09.009","volume":"38","author":"LW Harris","year":"2013","unstructured":"Harris LW, Guest PC, Wayland MT, Umrania Y, Krishnamurthy D, Rahmoune H, et al. Schizophrenia: metabolic aspects of aetiology, diagnosis and future treatment strategies. Psychoneuroendocrinology. 2013;38:752\u201366. https:\/\/doi.org\/10.1016\/j.psyneuen.2012.09.009.","journal-title":"Psychoneuroendocrinology"},{"key":"4955_CR105","doi-asserted-by":"publisher","first-page":"114582","DOI":"10.1016\/j.psychres.2022.114582","volume":"313","author":"X Li","year":"2022","unstructured":"Li X, Yuan X, Pang L, Zhang S, Li Y, Huang X, et al. The effect of serum lipids and short-chain fatty acids on cognitive functioning in drug-na\u00efve, first episode schizophrenia patients. Psychiatry Res. 2022;313:114582. https:\/\/doi.org\/10.1016\/j.psychres.2022.114582.","journal-title":"Psychiatry Res"},{"key":"4955_CR106","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1109\/91.413225","volume":"3","author":"NR Pal","year":"1995","unstructured":"Pal NR, Bezdek JC. On cluster validity for the fuzzy c-means model. IEEE Trans Fuzzy Syst. 1995;3:370\u20139. https:\/\/doi.org\/10.1109\/91.413225.","journal-title":"IEEE Trans Fuzzy Syst"},{"key":"4955_CR107","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1016\/j.fss.2010.07.005","volume":"161","author":"B Rezaee","year":"2010","unstructured":"Rezaee B. A cluster validity index for fuzzy clustering. Fuzzy Sets Syst. 2010;161:3014\u201325. https:\/\/doi.org\/10.1016\/j.fss.2010.07.005.","journal-title":"Fuzzy Sets Syst"},{"key":"4955_CR108","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ins.2022.11.010","volume":"618","author":"H-Y Wang","year":"2022","unstructured":"Wang H-Y, Wang J-S, Wang G. A survey of fuzzy clustering validity evaluation methods. Inf Sci. 2022;618:136\u201349. https:\/\/doi.org\/10.1016\/j.ins.2022.11.010.","journal-title":"Inf Sci"},{"key":"4955_CR109","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/schbul\/sbz112","volume":"46","author":"Y Pan","year":"2020","unstructured":"Pan Y, Pu W, Chen X, Huang X, Cai Y, Tao H, et al. Morphological profiling of schizophrenia: cluster analysis of MRI-based cortical thickness data. Schizophr Bull. 2020;46:623\u201332. https:\/\/doi.org\/10.1093\/schbul\/sbz112.","journal-title":"Schizophr Bull"},{"key":"4955_CR110","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.neubiorev.2019.09.006","volume":"107","author":"SP Carruthers","year":"2019","unstructured":"Carruthers SP, Van Rheenen TE, Gurvich C, Sumner PJ, Rossell SL. Characterising the structure of cognitive heterogeneity in schizophrenia spectrum disorders. A systematic review and narrative synthesis. Neurosci Biobehav Rev. 2019;107:252\u201378. https:\/\/doi.org\/10.1016\/j.neubiorev.2019.09.006.","journal-title":"Neurosci Biobehav Rev"},{"key":"4955_CR111","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41551-020-00614-8","volume":"5","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Wu W, Toll RT, Naparstek S, Maron-Katz A, Watts M, et al. Identification of psychiatric disorder subtypes from functional connectivity patterns in resting-state electroencephalography. Nat Biomed Eng. 2021;5:309\u201323. https:\/\/doi.org\/10.1038\/s41551-020-00614-8.","journal-title":"Nat Biomed Eng"},{"key":"4955_CR112","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol. 1995;57:289\u2013300. https:\/\/doi.org\/10.1111\/j.2517-6161.1995.tb02031.x.","journal-title":"J R Stat Soc Ser B Methodol"},{"key":"4955_CR113","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-84858-7","volume-title":"The elements of statistical learning","author":"T Hastie","year":"2009","unstructured":"Hastie T, Tibshirani R, Friedman J. The elements of statistical learning. New York: Springer; 2009. https:\/\/doi.org\/10.1007\/978-0-387-84858-7."},{"key":"4955_CR114","doi-asserted-by":"publisher","unstructured":"Akiba T, Sano S, Yanase T, Ohta T, Koyama M. Optuna: a next-generation hyperparameter optimization framework. In: Proceedings of the 25th ACM SIGKDD International Conference on Knowledge Discovery & Data Mining. New York: ACM; 2019. pp. 2623\u201331. https:\/\/doi.org\/10.1145\/3292500.3330701","DOI":"10.1145\/3292500.3330701"},{"key":"4955_CR115","first-page":"281","volume":"13","author":"J Bergstra","year":"2012","unstructured":"Bergstra J, Bengio Y. Random search for hyper-parameter optimization. J Mach Learn Res. 2012;13:281\u2013305. https:\/\/www.jmlr.org\/papers\/v13\/bergstra12a.html.","journal-title":"J Mach Learn Res"},{"key":"4955_CR116","doi-asserted-by":"publisher","first-page":"e1301","DOI":"10.1002\/widm.1301","volume":"9","author":"P Probst","year":"2019","unstructured":"Probst P, Wright M, Boulesteix A-L. Hyperparameters and tuning strategies for random forest. WIREs Data Min Knowl Discov. 2019;9:e1301. https:\/\/doi.org\/10.1002\/widm.1301.","journal-title":"WIREs Data Min Knowl Discov"},{"key":"4955_CR117","first-page":"1","volume":"18","author":"P Probst","year":"2018","unstructured":"Probst P, Boulesteix AL. To tune or not to tune the number of trees in random forest. J Mach Learn Res. 2018;18:1\u201318. https:\/\/www.jmlr.org\/papers\/v18\/17-269.html.","journal-title":"J Mach Learn Res"},{"key":"4955_CR118","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.biopsych.2022.07.025","volume":"93","author":"J Chen","year":"2023","unstructured":"Chen J, Patil KR, Yeo BTT, Eickhoff SB. Leveraging machine learning for gaining neurobiological and nosological insights in psychiatric research. Biol Psychiatry. 2023;93:18\u201328. https:\/\/doi.org\/10.1016\/j.biopsych.2022.07.025.","journal-title":"Biol Psychiatry"},{"key":"4955_CR119","doi-asserted-by":"publisher","first-page":"kkae005","DOI":"10.1093\/psyrad\/kkae005","volume":"4","author":"M Wang","year":"2024","unstructured":"Wang M, Zhao S-W, Wu D, Zhang Y-H, Han Y-K, Zhao K, et al. Transcriptomic and neuroimaging data integration enhances machine learning classification of schizophrenia. Psychoradiology. 2024;4:kkae005. https:\/\/doi.org\/10.1093\/psyrad\/kkae005.","journal-title":"Psychoradiology"},{"key":"4955_CR120","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12888-023-04701-3","volume":"23","author":"K Sakinyte","year":"2023","unstructured":"Sakinyte K, Holmberg C. Psychometric and clinical evaluation of schizophrenia remission criteria in outpatients with psychotic disorders. BMC Psychiatry. 2023;23:207. https:\/\/doi.org\/10.1186\/s12888-023-04701-3.","journal-title":"BMC Psychiatry"},{"key":"4955_CR121","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.neuroimage.2016.10.038","volume":"145","author":"G Varoquaux","year":"2017","unstructured":"Varoquaux G, Raamana PR, Engemann DA, Hoyos-Idrobo A, Schwartz Y, Thirion B. Assessing and tuning brain decoders: cross-validation, caveats, and guidelines. NeuroImage. 2017;145:166\u201379. https:\/\/doi.org\/10.1016\/j.neuroimage.2016.10.038.","journal-title":"NeuroImage"},{"key":"4955_CR122","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1038\/s41562-023-01670-1","volume":"7","author":"J Wu","year":"2023","unstructured":"Wu J, Li J, Eickhoff SB, Scheinost D, Genon S. The challenges and prospects of brain-based prediction of behaviour. Nat Hum Behav. 2023;7:1255\u201364. https:\/\/doi.org\/10.1038\/s41562-023-01670-1.","journal-title":"Nat Hum Behav"},{"key":"4955_CR123","first-page":"2079","volume":"11","author":"GC Cawley","year":"2010","unstructured":"Cawley GC, Talbot NLC. On over-fitting in model selection and subsequent selection bias in performance evaluation. J Mach Learn Res. 2010;11:2079\u2013107. https:\/\/www.jmlr.org\/papers\/v11\/cawley10a.html.","journal-title":"J Mach Learn Res"},{"key":"4955_CR124","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1192\/j.eurpsy.2021.2248","volume":"65","author":"L-H Lee","year":"2021","unstructured":"Lee L-H, Chen C-H, Chang W-C, Lee P-L, Shyu K-K, Chen M-H, et al. Evaluating the performance of machine learning models for automatic diagnosis of patients with schizophrenia based on a single site dataset of 440 participants. Eur Psychiatry. 2021;65:e1. https:\/\/doi.org\/10.1192\/j.eurpsy.2021.2248.","journal-title":"Eur Psychiatry"},{"key":"4955_CR125","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s40537-025-01193-8","volume":"12","author":"L Sasse","year":"2025","unstructured":"Sasse L, Nicolaisen-Sobesky E, Dukart J, Eickhoff SB, G\u00f6tz M, Hamdan S, et al. Overview of leakage scenarios in supervised machine learning. J Big Data. 2025;12:135. https:\/\/doi.org\/10.1186\/s40537-025-01193-8.","journal-title":"J Big Data"},{"key":"4955_CR126","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.schres.2017.07.006","volume":"193","author":"ES Gardsjord","year":"2018","unstructured":"Gardsjord ES, Romm KL, R\u00f8ssberg JI, Friis S, Barder HE, Evensen J, et al. Is going into stable symptomatic remission associated with a more positive development of life satisfaction? A 10-year follow-up study of first episode psychosis. Schizophr Res. 2018;193:364\u20139. https:\/\/doi.org\/10.1016\/j.schres.2017.07.006.","journal-title":"Schizophr Res"},{"key":"4955_CR127","volume-title":"Introduction to mediation, moderation, and conditional process analysis: a regression-based approach","author":"AF Hayes","year":"2017","unstructured":"Hayes AF. Introduction to mediation, moderation, and conditional process analysis: a regression-based approach. New York: Guilford; 2017."},{"key":"4955_CR128","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1503\/jpn.130283","volume":"40","author":"AM Shepherd","year":"2015","unstructured":"Shepherd AM, Quide Y, Laurens KR, O\u2019Reilly N, Rowland JE, Mitchell PB, et al. Shared intermediate phenotypes for schizophrenia and bipolar disorder: neuroanatomical features of subtypes distinguished by executive dysfunction. J Psychiatry Neurosci. 2015;40:58\u201368. https:\/\/doi.org\/10.1503\/jpn.130283.","journal-title":"J Psychiatry Neurosci"},{"key":"4955_CR129","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0165-1781(02)00036-7","volume":"110","author":"AM Cameron","year":"2002","unstructured":"Cameron AM, Oram J, Geffen GM, Kavanagh DJ, McGrath JJ, Geffen LB. Working memory correlates of three symptom clusters in schizophrenia. Psychiatry Res. 2002;110:49\u201361. https:\/\/doi.org\/10.1016\/S0165-1781(02)00036-7.","journal-title":"Psychiatry Res"},{"key":"4955_CR130","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.jpsychires.2006.07.005","volume":"40","author":"L Helldin","year":"2006","unstructured":"Helldin L, Kane JM, Karilampi U, Norlander T, Archer T. Remission and cognitive ability in a cohort of patients with schizophrenia. J Psychiatr Res. 2006;40:738\u201345. https:\/\/doi.org\/10.1016\/j.jpsychires.2006.07.005.","journal-title":"J Psychiatr Res"},{"key":"4955_CR131","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1017\/S0033291711000353","volume":"41","author":"A Hofer","year":"2011","unstructured":"Hofer A, Bodner T, Kaufmann A, Kemmler G, Mattarei U, Pfaffenberger NM, et al. Symptomatic remission and neurocognitive functioning in patients with schizophrenia. Psychol Med. 2011;41:2131\u20139. https:\/\/doi.org\/10.1017\/S0033291711000353.","journal-title":"Psychol Med"},{"key":"4955_CR132","doi-asserted-by":"publisher","first-page":"113607","DOI":"10.1016\/j.psychres.2020.113607","volume":"295","author":"M Thomas","year":"2021","unstructured":"Thomas M, Szentgyorgyi T, Vanes LD, Mouchlianitis E, Barry EF, Patel K, et al. Cognitive performance in early, treatment-resistant psychosis patients: could cognitive control play a role in persistent symptoms? Psychiatry Res. 2021;295:113607. https:\/\/doi.org\/10.1016\/j.psychres.2020.113607.","journal-title":"Psychiatry Res"},{"key":"4955_CR133","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/schbul\/sbw002","volume":"42","author":"S Raffard","year":"2016","unstructured":"Raffard S, Gutierrez L-A, Yazbek H, Larue A, Boulenger J-P, Lancon C, et al. Working memory deficit as a risk factor for severe apathy in schizophrenia: a 1-year longitudinal study. Schizophr Bull. 2016;42:642\u201351. https:\/\/doi.org\/10.1093\/schbul\/sbw002.","journal-title":"Schizophr Bull"},{"key":"4955_CR134","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.schres.2015.08.024","volume":"168","author":"OM Hager","year":"2015","unstructured":"Hager OM, Kirschner M, Bischof M, Hartmann-Riemer MN, Kluge A, Seifritz E, et al. Reward-dependent modulation of working memory is associated with negative symptoms in schizophrenia. Schizophr Res. 2015;168:238\u201344. https:\/\/doi.org\/10.1016\/j.schres.2015.08.024.","journal-title":"Schizophr Res"},{"key":"4955_CR135","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1080\/02699931.2012.751360","volume":"27","author":"QR Mano","year":"2013","unstructured":"Mano QR, Brown GG. Cognition\u2013emotion interactions in schizophrenia: emerging evidence on working memory load and implicit facial-affective processing. Cogn Emot. 2013;27:875\u201399. https:\/\/doi.org\/10.1080\/02699931.2012.751360.","journal-title":"Cogn Emot"},{"key":"4955_CR136","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00406-021-01237-z","volume":"271","author":"HF North","year":"2021","unstructured":"North HF, Bruggemann J, Cropley V, Swaminathan V, Sundram S, Lenroot R, et al. Increased peripheral inflammation in schizophrenia is associated with worse cognitive performance and related cortical thickness reductions. Eur Arch Psychiatry Clin Neurosci. 2021;271:595\u2013607. https:\/\/doi.org\/10.1007\/s00406-021-01237-z.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"4955_CR137","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.bbi.2024.03.014","volume":"118","author":"LS S\u00e6ther","year":"2024","unstructured":"S\u00e6ther LS, Szabo A, Akkouh IA, Haatveit B, Mohn C, Vaskinn A, et al. Cognitive and inflammatory heterogeneity in severe mental illness: translating findings from blood to brain. Brain Behav Immun. 2024;118:287\u201399. https:\/\/doi.org\/10.1016\/j.bbi.2024.03.014.","journal-title":"Brain Behav Immun"},{"key":"4955_CR138","doi-asserted-by":"publisher","first-page":"110668","DOI":"10.1016\/j.pnpbp.2022.110668","volume":"121","author":"SR Patlola","year":"2023","unstructured":"Patlola SR, Donohoe G, McKernan DP. The relationship between inflammatory biomarkers and cognitive dysfunction in patients with schizophrenia: a systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2023;121:110668. https:\/\/doi.org\/10.1016\/j.pnpbp.2022.110668.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"4955_CR139","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.schres.2014.04.041","volume":"161","author":"S Najjar","year":"2015","unstructured":"Najjar S, Pearlman DM. Neuroinflammation and white matter pathology in schizophrenia: systematic review. Schizophr Res. 2015;161:102\u201312. https:\/\/doi.org\/10.1016\/j.schres.2014.04.041.","journal-title":"Schizophr Res"},{"key":"4955_CR140","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s12888-023-04760-6","volume":"23","author":"Z Gao","year":"2023","unstructured":"Gao Z, Li B, Guo X, Bai W, Kou C. The association between schizophrenia and white blood cells count: a bidirectional two-sample Mendelian randomization study. BMC Psychiatry. 2023;23:271. https:\/\/doi.org\/10.1186\/s12888-023-04760-6.","journal-title":"BMC Psychiatry"},{"key":"4955_CR141","doi-asserted-by":"publisher","first-page":"581061","DOI":"10.3389\/fpsyt.2020.581061","volume":"11","author":"X Zhou","year":"2020","unstructured":"Zhou X, Wang X, Li R, Yan J, Xiao Y, Li W, et al. Neutrophil-to-lymphocyte ratio is independently associated with severe psychopathology in schizophrenia and is changed by antipsychotic administration: a large-scale cross-sectional retrospective study. Front Psychiatry. 2020;11:581061. https:\/\/doi.org\/10.3389\/fpsyt.2020.581061.","journal-title":"Front Psychiatry"},{"key":"4955_CR142","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.euroneuro.2023.01.002","volume":"69","author":"A Toll","year":"2023","unstructured":"Toll A, Blanco-Hinojo L, Berge D, Mart\u00edn-Subero M, Casanovas F, El-Abidi K, et al. Higher lymphocyte count associated with larger hippocampal volume and fewer depressive symptoms in drug-na\u00efve first-episode psychosis. Eur Neuropsychopharmacol. 2023;69:47\u201355. https:\/\/doi.org\/10.1016\/j.euroneuro.2023.01.002.","journal-title":"Eur Neuropsychopharmacol"},{"key":"4955_CR143","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.bbi.2025.04.024","volume":"128","author":"SR Patlola","year":"2025","unstructured":"Patlola SR, Holleran L, Dauvermann MR, Rokita K, Laighneach A, Hallahan B, et al. Investigating the relationship between toll-like receptor activity, low-grade inflammation and cognitive deficits in schizophrenia patients \u2013 a mediation analysis. Brain Behav Immun. 2025;128:529\u201339. https:\/\/doi.org\/10.1016\/j.bbi.2025.04.024.","journal-title":"Brain Behav Immun"},{"key":"4955_CR144","doi-asserted-by":"publisher","first-page":"1196760","DOI":"10.3389\/fpsyt.2023.1196760","volume":"14","author":"N Hu","year":"2023","unstructured":"Hu N, Li W, Deng H, Song J, Yang H, Chai J, et al. The mediating role of negative symptoms in secondary factors determining social functioning in chronic schizophrenia. Front Psychiatry. 2023;14:1196760. https:\/\/doi.org\/10.3389\/fpsyt.2023.1196760.","journal-title":"Front Psychiatry"},{"key":"4955_CR145","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1177\/0269881115616385","volume":"30","author":"E Elmorsy","year":"2016","unstructured":"Elmorsy E, Shahda M, Mahmoud E-HM, Rakha SA, Shoaib M. Blood lactate levels as a biomarker of antipsychotic side effects in patients with schizophrenia. J Psychopharmacol (Oxf). 2016;30:63\u20138. https:\/\/doi.org\/10.1177\/0269881115616385.","journal-title":"J Psychopharmacol (Oxf)"},{"key":"4955_CR146","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.5498\/wjp.v14.i9.1346","volume":"14","author":"W-M He","year":"2024","unstructured":"He W-M, Zhang X-Y, Xie W-G, Lv D-P, Shen Q-D. Expression level of myocardial enzymes in patients with schizophrenia: predictive value in the occurrence of violence. World J Psychiatry. 2024;14:1346\u201353. https:\/\/doi.org\/10.5498\/wjp.v14.i9.1346.","journal-title":"World J Psychiatry"},{"key":"4955_CR147","doi-asserted-by":"publisher","first-page":"106111","DOI":"10.1016\/j.bbi.2025.106111","volume":"130","author":"Y Fang","year":"2025","unstructured":"Fang Y, Zhang T, Xu K, Wang L, He J, Liao Y, et al. Dysregulated oxidative stress and lactate levels in treatment-resistant schizophrenia. Brain Behav Immun. 2025;130:106111. https:\/\/doi.org\/10.1016\/j.bbi.2025.106111.","journal-title":"Brain Behav Immun"},{"key":"4955_CR148","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/wps.20440","volume":"16","author":"MJ Owen","year":"2017","unstructured":"Owen MJ, O\u2019Donovan MC. Schizophrenia and the neurodevelopmental continuum: evidence from genomics. World Psychiatry. 2017;16:227\u201335. https:\/\/doi.org\/10.1002\/wps.20440.","journal-title":"World Psychiatry"},{"key":"4955_CR149","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1038\/s41467-020-16780-x","volume":"11","author":"DL Vetrano","year":"2020","unstructured":"Vetrano DL, Roso-Llorach A, Fern\u00e1ndez S, Guisado-Clavero M, Viol\u00e1n C, Onder G, et al. Twelve-year clinical trajectories of multimorbidity in a population of older adults. Nat Commun. 2020;11:3223. https:\/\/doi.org\/10.1038\/s41467-020-16780-x.","journal-title":"Nat Commun"},{"key":"4955_CR150","doi-asserted-by":"publisher","first-page":"e1002654","DOI":"10.1371\/journal.pmed.1002654","volume":"15","author":"MS Udler","year":"2018","unstructured":"Udler MS, Kim J, von Grotthuss M, Bon\u00e0s-Guarch S, Cole JB, Chiou J, et al. Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: a soft clustering analysis. PLOS Med. 2018;15:e1002654. https:\/\/doi.org\/10.1371\/journal.pmed.1002654.","journal-title":"PLOS Med"},{"key":"4955_CR151","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.euroneuro.2021.01.095","volume":"47","author":"S Amoretti","year":"2021","unstructured":"Amoretti S, Verdolini N, Mezquida G, Rabelo-da-Ponte FD, Cuesta MJ, Pina-Camacho L, et al. Identifying clinical clusters with distinct trajectories in first-episode psychosis through an unsupervised machine learning technique. Eur Neuropsychopharmacol. 2021;47:112\u201329. https:\/\/doi.org\/10.1016\/j.euroneuro.2021.01.095.","journal-title":"Eur Neuropsychopharmacol"},{"key":"4955_CR152","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41582-023-00779-1","volume":"19","author":"F Coutts","year":"2023","unstructured":"Coutts F, Koutsouleris N, McGuire P. Psychotic disorders as a framework for precision psychiatry. Nat Rev Neurol. 2023;19:221\u201334. https:\/\/doi.org\/10.1038\/s41582-023-00779-1.","journal-title":"Nat Rev Neurol"},{"key":"4955_CR153","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/npp.2009.164","volume":"35","author":"BJ Kinon","year":"2010","unstructured":"Kinon BJ, Chen L, Ascher-Svanum H, Stauffer VL, Kollack-Walker S, Zhou W, et al. Early response to antipsychotic drug therapy as a clinical marker of subsequent response in the treatment of schizophrenia. Neuropsychopharmacology. 2010;35:581\u201390. https:\/\/doi.org\/10.1038\/npp.2009.164.","journal-title":"Neuropsychopharmacology"},{"key":"4955_CR154","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s40265-021-01556-4","volume":"81","author":"M L\u00e4hteenvuo","year":"2021","unstructured":"L\u00e4hteenvuo M, Tiihonen J. Antipsychotic polypharmacy for the management of schizophrenia: evidence and recommendations. Drugs. 2021;81:1273\u201384. https:\/\/doi.org\/10.1007\/s40265-021-01556-4.","journal-title":"Drugs"},{"key":"4955_CR155","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1176\/appi.ajp.20220446","volume":"180","author":"H Taipale","year":"2023","unstructured":"Taipale H, Tanskanen A, Tiihonen J. Safety of antipsychotic polypharmacy versus monotherapy in a nationwide cohort of 61,889 patients with schizophrenia. Am J Psychiatry. 2023;180:377\u201385. https:\/\/doi.org\/10.1176\/appi.ajp.20220446.","journal-title":"Am J Psychiatry"},{"key":"4955_CR156","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.schres.2019.01.021","volume":"208","author":"E Wagner","year":"2019","unstructured":"Wagner E, Wobrock T, Kunze B, Langguth B, Landgrebe M, Eichhammer P, et al. Efficacy of high-frequency repetitive transcranial magnetic stimulation in schizophrenia patients with treatment-resistant negative symptoms treated with clozapine. Schizophr Res. 2019;208:370\u20136. https:\/\/doi.org\/10.1016\/j.schres.2019.01.021.","journal-title":"Schizophr Res"},{"key":"4955_CR157","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1007\/s00213-017-4616-7","volume":"234","author":"T Kishi","year":"2017","unstructured":"Kishi T, Matsuda Y, Iwata N. Memantine add-on to antipsychotic treatment for residual negative and cognitive symptoms of schizophrenia: a meta-analysis. Psychopharmacology. 2017;234:2113\u201325. https:\/\/doi.org\/10.1007\/s00213-017-4616-7.","journal-title":"Psychopharmacology"},{"key":"4955_CR158","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1017\/S0033291717001271","volume":"48","author":"W Zheng","year":"2018","unstructured":"Zheng W, Li X-H, Yang X-H, Cai D-B, Ungvari GS, Ng CH, et al. Adjunctive memantine for schizophrenia: a meta-analysis of randomized, double-blind, placebo-controlled trials. Psychol Med. 2018;48:72\u201381. https:\/\/doi.org\/10.1017\/S0033291717001271.","journal-title":"Psychol Med"},{"key":"4955_CR159","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1093\/schbul\/sbab022","volume":"47","author":"JA Lejeune","year":"2021","unstructured":"Lejeune JA, Northrop A, Kurtz MM. A meta-analysis of cognitive remediation for schizophrenia: efficacy and the role of participant and treatment factors. Schizophr Bull. 2021;47:997\u20131006. https:\/\/doi.org\/10.1093\/schbul\/sbab022.","journal-title":"Schizophr Bull"},{"key":"4955_CR160","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1038\/s41591-023-02540-z","volume":"29","author":"A Youssef","year":"2023","unstructured":"Youssef A, Pencina M, Thakur A, Zhu T, Clifton D, Shah NH. External validation of AI models in health should be replaced with recurring local validation. Nat Med. 2023;29:2686\u20137. https:\/\/doi.org\/10.1038\/s41591-023-02540-z.","journal-title":"Nat Med"},{"key":"4955_CR161","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1038\/s41591-021-01506-3","volume":"27","author":"I Dayan","year":"2021","unstructured":"Dayan I, Roth HR, Zhong A, Harouni A, Gentili A, Abidin AZ, et al. Federated learning for predicting clinical outcomes in patients with COVID-19. Nat Med. 2021;27:1735\u201343. https:\/\/doi.org\/10.1038\/s41591-021-01506-3.","journal-title":"Nat Med"},{"key":"4955_CR162","doi-asserted-by":"publisher","first-page":"kkae015","DOI":"10.1093\/psyrad\/kkae015","volume":"4","author":"T Paul","year":"2024","unstructured":"Paul T, See JW, Vijayakumar V, Njideaka-Kevin T, Loh H, Lee VJQ, et al. Neurostructural changes in schizophrenia and treatment-resistance: a narrative review. Psychoradiology. 2024;4:kkae015. https:\/\/doi.org\/10.1093\/psyrad\/kkae015.","journal-title":"Psychoradiology"},{"key":"4955_CR163","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.schres.2008.01.018","volume":"101","author":"S Leucht","year":"2008","unstructured":"Leucht S, Shamsi SAR, Busch R, Kissling W, Kane JM. Predicting antipsychotic drug response \u2013 replication and extension to six weeks in an international olanzapine study. Schizophr Res. 2008;101:312\u20139. https:\/\/doi.org\/10.1016\/j.schres.2008.01.018.","journal-title":"Schizophr Res"},{"key":"4955_CR164","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.biopsych.2010.01.012","volume":"68","author":"SZ Levine","year":"2010","unstructured":"Levine SZ, Leucht S. Elaboration on the early-onset hypothesis of antipsychotic drug action: treatment response trajectories. Biol Psychiatry. 2010;68:86\u201392. https:\/\/doi.org\/10.1016\/j.biopsych.2010.01.012.","journal-title":"Biol Psychiatry"},{"key":"4955_CR165","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1192\/bjp.bp.110.083907","volume":"199","author":"T Suzuki","year":"2011","unstructured":"Suzuki T, Remington G, Arenovich T, Uchida H, Agid O, Graff-Guerrero A, et al. Time course of improvement with antipsychotic medication in treatment-resistant schizophrenia. Br J Psychiatry. 2011;199:275\u201380. https:\/\/doi.org\/10.1192\/bjp.bp.110.083907.","journal-title":"Br J Psychiatry"},{"key":"4955_CR166","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1176\/appi.ajp.2015.14101329","volume":"172","author":"MT Samara","year":"2015","unstructured":"Samara MT, Leucht C, Leeflang MM, Anghelescu I-G, Chung Y-C, Crespo-Facorro B, et al. Early improvement as a predictor of later response to antipsychotics in schizophrenia: a diagnostic test review. Am J Psychiatry. 2015;172:617\u201329. https:\/\/doi.org\/10.1176\/appi.ajp.2015.14101329.","journal-title":"Am J Psychiatry"},{"key":"4955_CR167","doi-asserted-by":"publisher","first-page":"kkad007","DOI":"10.1093\/psyrad\/kkad007","volume":"3","author":"Q Wang","year":"2023","unstructured":"Wang Q, Wang Q, Zhang R-Y. Claim causality with clarity. Psychoradiology. 2023;3:kkad007. https:\/\/doi.org\/10.1093\/psyrad\/kkad007.","journal-title":"Psychoradiology"},{"key":"4955_CR168","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psychres.2017.06.010","volume":"256","author":"A Hofer","year":"2017","unstructured":"Hofer A, Radner V, Edlinger M, Kemmler G, Rettenbacher MA, Fleischhacker WW. Why do individuals with schizophrenia drop out of observational clinical trials? Psychiatry Res. 2017;256:1\u20135. https:\/\/doi.org\/10.1016\/j.psychres.2017.06.010.","journal-title":"Psychiatry Res"},{"key":"4955_CR169","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12888-016-0769-x","volume":"16","author":"E Johnsen","year":"2016","unstructured":"Johnsen E, Fathian F, Kroken RA, Steen VM, J\u00f8rgensen HA, Gjestad R, et al. The serum level of C-reactive protein (CRP) is associated with cognitive performance in acute phase psychosis. BMC Psychiatry. 2016;16:60. https:\/\/doi.org\/10.1186\/s12888-016-0769-x.","journal-title":"BMC Psychiatry"},{"key":"4955_CR170","doi-asserted-by":"publisher","first-page":"sbaf218","DOI":"10.1093\/schbul\/sbaf218","volume":"52","author":"T Zhang","year":"2026","unstructured":"Zhang T, Zhao X, Yeo BTT, Huo X, Eickhoff SB, Chen J. Leveraging stacked classifiers for multi-task executive function in schizophrenia yields diagnostic and prognostic insights. Schizophr Bull. 2026;52:sbaf218. https:\/\/doi.org\/10.1093\/schbul\/sbaf218.","journal-title":"Schizophr Bull"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-04955-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04955-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04955-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T22:34:40Z","timestamp":1784759680000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-026-04955-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":170,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4955"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-04955-0","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in full compliance with the appropriate ethical guidelines and was approved by the Ethics Committees of the Third People\u2019s Hospital of Lanzhou City and Northwest Normal University (Lanzhou, China; ethics approval nos. TPHL202303 and NWNU202404). All participants provided written informed consent after receiving comprehensive information about the study aims, procedures, potential risks, and benefits. The study adhered to the principles outlined in the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We declare that Dr. Ji Chen is an Editorial Board Member of\n                      BMC Medicine\n                      . The authors declare no competing interests.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"403"}}